在慢性淋巴细胞白血病中,Venetoclax剂量升级迅速激活BAFF/BCL-2生存轴
Meng-Xiao Luo1,2, Tania Tan1,2, Marie Trussart1,2
1The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
Blood
|October 29, 2024
概括
慢性淋巴细胞白血病 (CLL) 的Venetoclax治疗迅速改变癌细胞,增加生存蛋白和细胞因子信号传递. 针对这些适应机制可能会改善患者对向治疗的长期反应.
科学领域:
- 血液学 血液学 血液学
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
背景情况:
- 作为B细胞淋巴瘤-2 (BCL-2) 抑制剂的Venetoclax已经改变了慢性淋巴细胞白血病 (CLL) 的治疗方法.
- 早期反应深度预测了长期结果,但早期治疗适应机制尚不清楚.
研究的目的:
- 在venetoclax单独治疗期间调查CLL患者的早期细胞变化.
- 确定CLL细胞对向治疗的适应机制.
主要方法:
- 纵向质量细胞测量对CLL患者的血细胞在5周的venetoclax治疗中进行分析.
- 对CLL异质性和蛋白质表达的单细胞分析.
- 鼠标模型验证发现并评估B细胞激活因子 (BAFF) 的作用.
主要成果:
- 维内托克拉克斯减少了所有CLL亚群,但在幸存细胞中诱导了生存蛋白 (BCL-2,BCL-XL,MCL-1) 的上调.
- 在接受venetoclax或obinutuzumab治疗的患者的CLL细胞中观察到增加的生存蛋白和BAFF.
- 鼠标模型证实了生存蛋白持续升高,并突出了亡和BAFF的重要作用.
结论:
- 通过上调生存蛋白质和利用细胞因子信号传递 (BAFF),CLL细胞迅速适应venetoclax.
- 与venetoclax一起针对细胞因子信号可能会提高CLL的反应深度和耐久性.
- 了解这些适应机制对于优化向治疗策略至关重要.
相关概念视频
01:31The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:24B Cell Activation and Differentiation
1.6K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.6K